The ISPOR eBULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to: www.ispor.org. Please share these new ISPOR activities with your colleagues.
NEW! "About ISPOR" Now Available
The “About ISPOR” booklet, a review of ISPOR’s growth and achievements, is now available in PDF format.
"About ISPOR" »
2010 ISPOR Board of Directors Election
This is a reminder to vote for the 2010-2011 ISPOR Board of Directors candidates. In this election, you have the opportunity to vote for the President-Elect (term of office 2010-2011 and as President 2011-2012) and four Directors (2010-2012). Please vote online via the ISPOR website.
ISPOR Board of Directors Election 2010 »
*Deadline to vote is: April 6, 2010.
ISPOR 15th Annual International Meeting, Atlanta, GA, USA: May 15-19, 2010
**COMPLETE PROGRAM (INCLUDING 1117 CONTRIBUTED PRESENTATIONS) NOW AVAILABLE**
15th Annual International Meeting Program »
ISPOR 4th Asia-Pacific Conference, Phuket, Thailand:
5-7 September, 2010
*Call For Abstracts Deadline: 18 March 2010
ISPOR 4th Asia-Pacific Conference »
ISPOR 13th Annual European Congress, Prague, Czech Republic: 6-9 November 2010
*Call For Abstracts Deadline: 22 June 2010
For sponsorship, exhibit, advertising and symposium opportunities, see:
ISPOR 13th Annual European Congress »
NEW! Value in Health Early View Articles
23 Early View articles are available on-line.
Value in Health Early View articles »
NEW! Value in Health Volume 13, Issue 2 On-Line
Value in Health Volume 13, Issue 2 is now available on-line.
Value in Health Volume 13, Issue 2 »
NEW! ISPOR CONNECTIONS Volume 16, Issue 1 Now On-Line
ISPOR CONNECTIONS January/February 2010 is now available on-line. Articles include:Thoughts on the Validity of a New QALY EstimatorHealth Care Decision-Making Around the World: A Global Roadmap and Country-Specific Decision-Making and Reimbursement ProcessesAssessment of Use of Pharmacoeconomics and Outcomes Research in Asia: The ISPOR Asia Consortium Needs Survey Report.
ISPOR CONNECTIONS Volume 16, Issue 1 »
ISPOR REGIONAL CHAPTERS/CONSORTIA
NEW! 9th International Symposium for Health Economics
The São Paulo Center for Health Economics hosts the 9th International Symposium for Health Economics: Sustainability of the Health Care Sector, 27-29 April 2010 in São Paulo, Brazil. For further information visit:
ISPOR Brazil Chapter »
ISPOR SPECIAL INTEREST GROUPS/TASK FORCES
To join a Special Interest Group (SIG), see:
ISPOR Join Special Interest Group »
NEW! ePRO Working Group
The ePRO Working Group is initiating two NEW Good Research Practices manuscript projects. The the NEW ePRO Working Group Chair is Arthur S. (Art) Zbrozek RPh, MSc, MBA, Senior Director, Health Care Relations, Field Economics Team, AstraZeneca Pharmaceuticals, Wilmington, DE, USA, and will chair the ePRO Systems Validation Manuscript Team.
The ePRO Systems Validation Subgroup »
The ePRO Mixed Modalities Manuscript Team will be led by Sonya Eremenco MA, ePRO Manager, United BioSource Corporation, Bethesda, MD, USA.
Mixed Modalities Manuscript Project »
If you are interested in actively participating in either of these manuscript projects or would like to join the ePRO Working Group as a Review Group member, please contact: email@example.com.
ISPOR Oncology Special Interest Group (SIG)
ISPOR first disease-specific Special Interest Group was launched in February 2010 with the goal to address specific oncology outcomes research issues and to provide a forum for oncology researchers as well as oncology clinicians to promote the sharing of knowledge about oncology outcomes research. The ISPOR Oncology Outcomes Research Working Group was formed under the umbrella of the Oncology SIG, with the following objectives:
Identify specific clinical information that outcomes researchers need to know in order to conduct good oncology outcomes research.
Develop a repository of different oncology resources on the ISPOR website including links to related websites, guidelines, and articles that provide the necessary knowledge to help enhance the quality of oncology outcomes research.
For more information, see: ISPOR Oncology Outcomes Research Working Group. To join this Working Group, see: ISPOR Join Special Interest Group »
MSc in Health Economics Policy and Management
Founded in 1895, the London School of Economics and Political Science is now the world’s leading dedicated social science institution. The School is offering healthcare, pharmaceutical and public sector professionals a unique opportunity to work full time and gain formal qualifications at the same time in topics such as:
health management and administration ● health economics cost-effectiveness and statistical analysis ● health policy ● pharmaceutical economics ● epidemiology/clinical trials ● health information systems
This modular MSc programme is operated by LSE Health
(http://www2.lse.ac.uk/LSEHealthAndSocialCare/LSEHealth/Home.aspx) and the Department of Social Policy
(http://www2.lse.ac.uk/socialPolicy/Home.aspx) at the London School of Economics and Political Science.
Additional teaching is provided by the Department of Management and the European Institute as well as subject experts from other UK academic institutions.
The programme starts in December 2010. The MSc will take two years to complete with two intensive sessions each academic year - December 2010, June 2011, December 2011 and June 2012. The MSc will require a total of 41 days in London for teaching and examinations over two years with extensive off-site support in-between.
Diploma and certificate options are also available. For additional information please contact:
Learn research in the newly funded area of comparative effectiveness studies.
Register Today! Visit: www.hsph.harvard.edu/ccpe/MDA or call: 617-384-8692
Taught in an interactive classroom setting, this program is geared towards introductory to intermediate learning levels to help participants design, implement, and analyze outcomes studies, and critically review and use outcomes data for clinical decision making, health care planning, and technology development. The program provides participants with an overview of several topics in the newly funded field of comparative effectiveness studies, equipping newcomers with knowledge of the language and concepts.
"The U.S. spends more than $2 trillion a year on health care, but we have little information about which treatments work best for which patients." — Representative Pete Stark, Democrat of California
Chairman of the Ways and Means Subcommittee on Health
The economic stimulus bill approved by Congress, for the first time, provides substantial amounts of money to compare the effectiveness of different treatments for the same illness, responding to a growing concern that doctors have little or no solid evidence of the value of many treatments.
In an increasingly competitive health care market, outcomes evaluation and research is important for:
Improving patient outcomes ● Controlling costs and allocating resources ● Implementing disease management programs ● Making effective clinical and business decisions ● Developing and marketing health care products and services ● Saving money by discouraging the use of costly, ineffective treatments
Improving your analytical and quantitative skills will greatly enhance the use of health outcomes research at your organization.
"This is an excellent program, covering a wide range of health economic and outcomes related topics, and taught by an expert faculty. Great for those wanting to gain or improve their knowledge in outcomes research and underlying methods."— Steven Blum, Associate Director, Health Economics, Forest Research Institute, Jersey City, NJ, USA.
CME and CEU Credits Available. For a detailed agenda or to register, visit: www.hsph.harvard.edu/ccpe/MDA or call: 617-384-8692. Please be sure to mention your Reference Code: MDA10-IP01 in all correspondence.
This program is recognized by the Society for Risk Analysis.
TIP OF THE MONTH- ISPOR Website Site Map
The Site Map on the ISPOR homepage gives you a quick and comprehensive look at the ISPOR website and provides over 20 ISPOR areas of interests and links to many useful resources. To access the ISPOR Site Map, simply click the Site Map Link on the ISPOR website homepage.
This newsletter is provided as a benefit of membership in
ISPOR. If you received this from a colleague and are not a current
ISPOR member, please consider becoming an
individual member or organizational affiliate. Contact membership
services for more information and its use in health care decisions.
The International Society for
Pharmacoeconomics and Outcomes Research is an international organization
promoting the science of pharmacoeconomics and health outcomes research.
3100 Princeton Pike, Suite 3E, Lawrenceville, NJ, 08648 USA
Toll Free: 1-800-992-0643 Fax: 609-219-0774